10. Cardiovascular Disease and Risk Management: Standards of Care in Diabetes—2025

Cites (325)

Items 201–360 of 360

1. The CardioMetabolic Health Alliance
   Sperling, Laurence S., Mechanick, Jeffrey I., Neeland, Ian J., Herrick, Cynthia J., Després, Jean-Pierre, Ndumele, Chiadi E., Vijayaraghavan, Krishnaswami, Handelsman, Yehuda, Puckrein, Gary A., Araneta, Maria Rosario G. et al. · 2015 · Journal of the American College of Cardiology
2. Pravastatin and cognitive function in the elderly. Results of the PROSPER study
   Trompet, Stella, Vliet, Peter, Craen, Anton J. M., Jolles, Jelle, Buckley, Brendan M., Murphy, Michael B., Ford, Ian, Macfarlane, Peter W., Sattar, Naveed, Packard, Chris J. et al. · 2010 · Journal of Neurology
3. Diabetes as a risk factor for heart failure in women and men: a systematic review and meta-analysis of 47 cohorts including 12 million individuals
   Ohkuma, Toshiaki, Komorita, Yuji, Peters, Sanne A. E., Woodward, Mark · 2019 · Diabetologia
4. Effects of intensive blood pressure reduction on myocardial infarction and stroke in diabetes: a meta-analysis in 73 913 patients
   Reboldi, Gianpaolo, Gentile, Giorgio, Angeli, Fabio, Ambrosio, Giuseppe, Mancia, Giuseppe, Verdecchia, Paolo · 2011 · Journal of Hypertension
5. Additive Beneficial Effects of Beta-Blockers to Angiotensin-Converting Enzyme Inhibitors in the Survival and Ventricular Enlargement (SAVE) Study fn1fn1This study was supported by a University-Industry grant from the Medical Research Council, Ottawa, Ontario, Canada and Bristol Myers Squibb, Montreal, Quebec, Canada.
   Vantrimpont, Pascal, Rouleau, Jean L., Wun, Chuan-Chuan, Ciampi, Antonio, Klein, Marc, Sussex, Bruce, Arnold, J.Malcolm O., Moyé, Lemuel, Pfeffer, Marc · 1997 · Journal of the American College of Cardiology
6. Nonfasting mild-to-moderate hypertriglyceridemia and risk of acute pancreatitis
   Pedersen, Simon B., Langsted, Anne, Nordestgaard, Børge G. · 2016 · JAMA Internal Medicine
7. Coronary calcium measurement improves prediction of cardiovascular events in asymptomatic patients with type 2 diabetes: the PREDICT study
   Elkeles, R. S., Godsland, I. F., Feher, M. D., Rubens, M. B., Roughton, M., Nugara, F., Humphries, S. E., Richmond, W., Flather, M. D., for the PREDICT Study Group · 2008 · European Heart Journal
8. Safety and efficacy of anti-PCSK9 antibodies: a meta-analysis of 25 randomized, controlled trials
   Zhang, Xin-Lin, Zhu, Qing-Qing, Zhu, Li, Chen, Jian-Zhou, Chen, Qin-Hua, Li, Guan-Nan, Xie, Jun, Kang, Li-Na, Xu, Biao · 2015 · BMC Medicine
9. Efficacy and Safety of Dapagliflozin in Patients With Inadequately Controlled Type 1 Diabetes (the DEPICT-2 Study): 24-Week Results From a Randomized Controlled Trial
   Mathieu, Chantal, Dandona, Paresh, Gillard, Pieter, Senior, Peter, Hasslacher, Christoph, Araki, Eiichi, Lind, Marcus, Bain, Stephen C., Jabbour, Serge, Arya, Niki et al. · 2018 · Diabetes Care
10. Evaluation of the Cascade of Diabetes Care in the United States, 2005-2016
    Kazemian, Pooyan, Shebl, Fatma M., McCann, Nicole, Walensky, Rochelle P., Wexler, Deborah J. · 2019 · JAMA Internal Medicine
11. Statins and Cognitive Function: A Systematic Review
    Richardson, Karl, Schoen, Marisa, French, Benjamin, Umscheid, Craig A., Mitchell, Matthew D., Arnold, Steven E., Heidenreich, Paul A., Rader, Daniel J., deGoma, Emil M. · 2013 · Annals of Internal Medicine
12. Detection of Coronary Artery Disease in Asymptomatic Patients With Type 2 Diabetes Mellitus
    Scognamiglio, Roldano, Negut, Christian, Ramondo, Angelo, Tiengo, Antonio, Avogaro, Angelo · 2006 · Journal of the American College of Cardiology
13. Sodium‐Glucose Cotransporter 2 Inhibition for the Prevention of Cardiovascular Events in Patients With Type 2 Diabetes Mellitus: A Systematic Review and Meta‐Analysis
    Arnott, Clare, Li, Qiang, Kang, Amy, Neuen, Brendon L., Bompoint, Severine, Lam, Carolyn S. P., Rodgers, Anthony, Mahaffey, Kenneth W., Cannon, Christopher P., Perkovic, Vlado et al. · 2020 · Journal of the American Heart Association
14. The SGLT2 inhibitor canagliflozin in heart failure: the CHIEF-HF remote, patient-centered randomized trial
    Spertus, John A., Birmingham, Mary C., Nassif, Michael, Damaraju, C. V., Abbate, Antonio, Butler, Javed, Lanfear, David E., Lingvay, Ildiko, Kosiborod, Mikhail N., Januzzi, James L. · 2022 · Nature Medicine
15. Cardiovascular Events During Differing Hypertension Therapies in Patients With Diabetes
    Weber, Michael A., Bakris, George L., Jamerson, Kenneth, Weir, Matthew, Kjeldsen, Sverre E., Devereux, Richard B., Velazquez, Eric J., Dahlöf, Björn, Kelly, Roxzana Y., Hua, Tsushung A. et al. · 2010 · Journal of the American College of Cardiology
16. Efficacy and safety of dual blockade of the renin-angiotensin system: meta-analysis of randomised trials
    Makani, H., Bangalore, S., Desouza, K. A., Shah, A., Messerli, F. H. · 2013 · BMJ
17. Incidence of Hospitalization for Heart Failure and Case-Fatality Among 3.25 Million People With and Without Diabetes Mellitus
    McAllister, David A., Read, Stephanie H., Kerssens, Jan, Livingstone, Shona, McGurnaghan, Stuart, Jhund, Pardeep, Petrie, John, Sattar, Naveed, Fischbacher, Colin, Kristensen, Soren Lund et al. · 2018 · Circulation
18. Use of Coronary Artery Calcium Testing to Guide Aspirin Utilization for Primary Prevention: Estimates From the Multi-Ethnic Study of Atherosclerosis
    Michael D. Miedema, Daniel A. Duprez, Jeffrey R. Misialek, Michael Joseph Blaha, Khurram Nasir, Michael G. Silverman, Ron Blankstein, Matthew Jay Budoff, Philip Greenland, Aaron R. Folsom · 2014 · Circulation Cardiovascular Quality and Outcomes
19. Effects of empagliflozin on risk for cardiovascular death and heart failure hospitalization across the spectrum of heart failure risk in the EMPA-REG OUTCOME® trial
    Fitchett, David, Butler, Javed, van de Borne, Philippe, Zinman, Bernard, Lachin, John M, Wanner, Christoph, Woerle, Hans J, Hantel, Stefan, George, Jyothis T, Johansen, Odd Erik et al. · 2018 · European Heart Journal
20. Antihypertensive drug therapy for mild to moderate hypertension during pregnancy
    Abalos, Edgardo, Duley, Lelia, Steyn, D Wilhelm, Gialdini, Celina · 2018 · Cochrane Database of Systematic Reviews
21. A Simplified Approach to the Treatment of Uncomplicated Hypertension: A Cluster Randomized, Controlled Trial
    Feldman, Ross D., Zou, Guang Y., Vandervoort, Margaret K., Wong, Cindy J., Nelson, Sigrid A.E., Feagan, Brian G. · 2009 · Hypertension
22. Population screening and intervention for vascular disease in Danish men (VIVA): a randomised controlled trial
    Lindholt, Jes S, Søgaard, Rikke · 2017 · The Lancet
23. Primary prevention of cardiovascular disease with atorvastatin in type 2 diabetes in the Collaborative Atorvastatin Diabetes Study (CARDS): Multicentre randomised placebo-controlled trial
    Helen Martina Colhoun, D.J. Betteridge, P Durrington · 2004 · ACC Current Journal Review
24. Women, lipids, and atherosclerotic cardiovascular disease: a call to action from the European Atherosclerosis Society
    Roeters van Lennep, Jeanine E, Tokgözoğlu, Lale S, Badimon, Lina, Dumanski, Sandra M, Gulati, Martha, Hess, Connie N, Holven, Kirsten B, Kavousi, Maryam, Kayıkçıoğlu, Meral, Lutgens, Esther et al. · 2023 · European Heart Journal
25. Consistency With the DASH Diet and Incidence of Heart Failure
    Levitan, Emily B., Wolk, Alicja, Mittleman, Murray A. · 2009 · Archives of Internal Medicine
26. Heart failure and chronic kidney disease manifestation and mortality risk associations in type 2 diabetes: A large multinational cohort study
    Birkeland, Kåre I., Bodegard, Johan, Eriksson, Jan W., Norhammar, Anna, Haller, Hermann, Linssen, Gerard C.M., Banerjee, Amitava, Thuresson, Marcus, Okami, Suguru, Garal‐Pantaler, Elena et al. · 2020 · Diabetes, Obesity and Metabolism
27. Reduction in ischemic events with ticagrelor in diabetic patients with prior myocardial infarction in PEGASUS–TIMI 54
    Bhatt, Deepak L., Bonaca, Marc P., Bansilal, Sameer, Angiolillo, Dominick J., Cohen, Marc, Storey, Robert F., Im, Kyungah, Murphy, Sabina A., Held, Peter, Braunwald, Eugene et al. · 2016 · Journal of the American College of Cardiology
28. Coronary Artery Calcium Score for Long-term Risk Classification in Individuals With Type 2 Diabetes and Metabolic Syndrome From the Multi-Ethnic Study of Atherosclerosis
    Malik, Shaista, Zhao, Yanglu, Budoff, Matthew, Nasir, Khurram, Blumenthal, Roger S., Bertoni, Alain G., Wong, Nathan D. · 2017 · JAMA Cardiology
29. Influence of Time of Day of Blood Pressure–Lowering Treatment on Cardiovascular Risk in Hypertensive Patients With Type 2 Diabetes
    Hermida, Ramón C., Ayala, Diana E., Mojón, Artemio, Fernández, José R. · 2011 · Diabetes Care
30. Design and baseline characteristics of the CARdiovascular Outcome Trial of LINAgliptin Versus Glimepiride in Type 2 Diabetes (CAROLINA ^® )
    Marx, Nikolaus, Rosenstock, Julio, Kahn, Steven E, Zinman, Bernard, Kastelein, John J, Lachin, John M, Espeland, Mark A, Bluhmki, Erich, Mattheus, Michaela, Ryckaert, Bart et al. · 2015 · Diabetes and Vascular Disease Research
31. Incidence and determinants of hyperkalemia and hypokalemia in a large healthcare system
    Nilsson, Erik, Gasparini, Alessandro, Ärnlöv, Johan, Xu, Hairong, Henriksson, Karin M., Coresh, Josef, Grams, Morgan E., Carrero, Juan Jesus · 2017 · International Journal of Cardiology
32. Ticagrelor in patients with diabetes and stable coronary artery disease with a history of previous percutaneous coronary intervention (THEMIS-PCI): a phase 3, placebo-controlled, randomised trial
    Bhatt, Deepak L, Steg, Philippe Gabriel, Mehta, Shamir R, Leiter, Lawrence A, Simon, Tabassome, Fox, Kim, Held, Claes, Andersson, Marielle, Himmelmann, Anders, Ridderstråle, Wilhelm et al. · 2019 · The Lancet
33. Effects of blood-pressure-lowering treatment on outcome incidence in hypertension: 10 – Should blood pressure management differ in hypertensive patients with and without diabetes mellitus? Overview and meta-analyses of randomized trials
    Thomopoulos, Costas, Parati, Gianfranco, Zanchetti, Alberto · 2017 · Journal of Hypertension
34. American Association Of Clinical Endocrinologists And American College Of Endocrinology Guidelines For Management Of Dyslipidemia And Prevention Of Cardiovascular Disease - Executive Summary
    Paul S. Jellinger, Yehuda Handelsman, Paul D. Rosenblit, Zachary T. Bloomgarden, Vivian Andrew Fonseca, A GARBER, George Grunberger, Chris K. Guerin, DavidS H. Bell, Jeffrey Ian Mechanick et al. · 2017 · Endocrine Practice
35. Aspirin, Statins, or Both Drugs for the Primary Prevention of Coronary Heart Disease Events in Men: A Cost–Utility Analysis
    Pignone, Michael, Earnshaw, Stephanie, Tice, Jeffrey A., Pletcher, Mark J. · 2006 · Annals of Internal Medicine
36. Fixed Low-Dose Triple Combination Antihypertensive Medication vs Usual Care for Blood Pressure Control in Patients With Mild to Moderate Hypertension in Sri Lanka: A Randomized Clinical Trial
    Webster, Ruth, Salam, Abdul, de Silva, H. Asita, Selak, Vanessa, Stepien, Sandrine, Rajapakse, Senaka, Amarasekara, Stanley, Amarasena, Naomali, Billot, Laurent, de Silva, Arjuna P. et al. · 2018 · JAMA
37. Association between renin-angiotensin system blockade discontinuation and all-cause mortality among persons with low estimated glomerular filtration rate
    Qiao, Yao, Shin, Jung-Im, Chen, Teresa K., Inker, Lesley A., Coresh, Josef, Alexander, G. Caleb, Jackson, John W., Chang, Alex R., Grams, Morgan E. · 2020 · JAMA Internal Medicine
38. Statin use and risk of dementia or Alzheimer's disease: a systematic review and meta-analysis of observational studies
    Olmastroni, Elena, Molari, Giulia, De Beni, Noemi, Colpani, Ornella, Galimberti, Federica, Gazzotti, Marta, Zambon, Alberto, Catapano, Alberico L, Casula, Manuela · 2022 · European Journal of Preventive Cardiology
39. NLA scientific statement on statin intolerance: a new definition and key considerations for ASCVD risk reduction in the statin intolerant patient
    Cheeley, Mary Katherine, Saseen, Joseph J., Agarwala, Anandita, Ravilla, Sudha, Ciffone, Nicole, Jacobson, Terry A., Dixon, Dave L., Maki, Kevin C. · 2022 · Journal of Clinical Lipidology
40. Microvascular disease, peripheral artery disease, and amputation
    Beckman, Joshua A., Duncan, Meredith S., Damrauer, Scott M., Wells, Quinn S., Barnett, Joey V., Wasserman, David H., Bedimo, Roger J., Butt, Adeel A., Marconi, Vincent C., Sico, Jason J. et al. · 2019 · Circulation
41. Contribution of Major Lifestyle Risk Factors for Incident Heart Failure in Older Adults
    Del Gobbo, Liana C., Kalantarian, Shadi, Imamura, Fumiaki, Lemaitre, Rozenn, Siscovick, David S., Psaty, Bruce M., Mozaffarian, Dariush · 2015 · JACC: Heart Failure
42. Stroke Prevention With the PCSK9 (Proprotein Convertase Subtilisin-Kexin Type 9) Inhibitor Evolocumab Added to Statin in High-Risk Patients With Stable Atherosclerosis
    Giugliano, Robert P., Pedersen, Terje R., Saver, Jeffrey L., Sever, Peter S., Keech, Anthony C., Bohula, Erin A., Murphy, Sabina A., Wasserman, Scott M., Honarpour, Narimon, Wang, Huei et al. · 2020 · Stroke
43. Diabetes mellitus as a compelling indication for use of renin angiotensin system blockers: systematic review and meta-analysis of randomized trials
    Bangalore, Sripal, Fakheri, Robert, Toklu, Bora, Messerli, Franz H · 2016 · BMJ
44. Metoprolol Reverses Left Ventricular Remodeling in Patients With Asymptomatic Systolic Dysfunction: The REversal of VEntricular Remodeling with Toprol-XL (REVERT) Trial
    Colucci, Wilson S., Kolias, Theodore J., Adams, Kirkwood F., Armstrong, William F., Ghali, Jalal K., Gottlieb, Stephen S., Greenberg, Barry, Klibaner, Michael I., Kukin, Marrick L., Sugg, Jennifer E. · 2007 · Circulation
45. Hyperkalemia after initiating renin-angiotensin system blockade: the Stockholm Creatinine Measurements (SCREAM) project
    Bandak, Ghassan, Sang, Yingying, Gasparini, Alessandro, Chang, Alex R., Ballew, Shoshana H., Evans, Marie, Arnlov, Johan, Lund, Lars H., Inker, Lesley A., Coresh, Josef et al. · 2017 · Journal of the American Heart Association
46. Beta-adrenergic blocking agent use and mortality in patients with asymptomatic and symptomatic left ventricular systolic dysfunction: a post hoc analysis of the Studies of Left Ventricular Dysfunction
    Exner, Derek V, Dries, Daniel L, Waclawiw, Myron A, Shelton, Brent, Domanski, Michael J · 1999 · Journal of the American College of Cardiology
47. Effect of 1 or 2 Doses of Inclisiran on Low-Density Lipoprotein Cholesterol Levels: One-Year Follow-up of the ORION-1 Randomized Clinical Trial
    Ray, Kausik K., Stoekenbroek, Robert M., Kallend, David, Nishikido, Toshiyuki, Leiter, Lawrence A., Landmesser, Ulf, Wright, R. Scott, Wijngaard, Peter L. J., Kastelein, John J. P. · 2019 · JAMA Cardiology
48. Temporal trends and factors associated with diabetes mellitus among patients hospitalized with heart failure: Findings from Get With The Guidelines-Heart Failure registry
    Echouffo-Tcheugui, Justin B., Xu, Haolin, DeVore, Adam D., Schulte, Phillip J., Butler, Javed, Yancy, Clyde W., Bhatt, Deepak L., Hernandez, Adrian F., Heidenreich, Paul A., Fonarow, Gregg C. · 2016 · American Heart Journal
49. Role of Combination Antiplatelet and Anticoagulation Therapy in Diabetes Mellitus and Cardiovascular Disease: Insights From the COMPASS Trial
    Bhatt, Deepak L., Eikelboom, John W., Connolly, Stuart J., Steg, P. Gabriel, Anand, Sonia S., Verma, Subodh, Branch, Kelley R.H., Probstfield, Jeffrey, Bosch, Jackie, Shestakovska, Olga et al. · 2020 · Circulation
50. Efficacy and safety of alirocumab, a monoclonal antibody to PCSK9, in statin-intolerant patients: design and rationale of ODYSSEY ALTERNATIVE, a randomized phase 3 trial
    Moriarty, Patrick M., Jacobson, Terry A., Bruckert, Eric, Thompson, Paul D., Guyton, John R., Baccara-Dinet, Marie T., Gipe, Daniel · 2014 · Journal of Clinical Lipidology
51. Blood pressure targets for hypertension in people with diabetes mellitus
    Arguedas, Jose Agustin, Leiva, Viriam, Wright, James M · 2013 · Cochrane Database of Systematic Reviews
52. PCSK9 inhibitors and ezetimibe with or without statin therapy for cardiovascular risk reduction: a systematic review and network meta-analysis
    Khan, Safi U, Yedlapati, Siva H, Lone, Ahmad N, Hao, Qiukui, Guyatt, Gordon, Delvaux, Nicolas, Bekkering, Geertruida E (Trudy), Vandvik, Per Olav, Riaz, Irbaz Bin, Li, Sheyu et al. · 2022 · BMJ
53. Aspirin for primary prevention of cardiovascular events in patients with diabetes: A meta-analysis
    Zhang, Chunyu, Sun, Aijun, Zhang, Peng, Wu, Chaoneng, Zhang, Shuning, Fu, Mingqiang, Wang, Keqiang, Zou, Yunzeng, Ge, Junbo · 2010 · Diabetes Research and Clinical Practice
54. Bempedoic Acid for Primary Prevention of Cardiovascular Events in Statin-Intolerant Patients
    Nissen, Steven E., Menon, Venu, Nicholls, Stephen J., Brennan, Danielle, Laffin, Luke, Ridker, Paul, Ray, Kausik K., Mason, Denise, Kastelein, John J. P., Cho, Leslie et al. · 2023 · JAMA
55. Biomarker-based risk prediction of incident heart failure in pre-diabetes and diabetes
    Pandey, Ambarish, Vaduganathan, Muthiah, Patel, Kershaw V., Ayers, Colby, Ballantyne, Christie M., Kosiborod, Mikhail N., Carnethon, Mercedes, DeFilippi, Christopher, McGuire, Darren K., Khan, Sadiya S. et al. · 2021 · JACC: Heart Failure
56. Effect of type 2 diabetes and its duration on the risk of peripheral arterial disease among men
    Al-Delaimy, Wael K, Merchant, Anwar T, Rimm, Eric B, Willett, Walter C, Stampfer, Meir J, Hu, Frank B · 2004 · The American Journal of Medicine
57. Sex Differences in Diabetes and Risk of Incident Coronary Artery Disease in Healthy Young and Middle-Aged Adults
    Rita Rastogi Kalyani, Mariana Lazo, Pamela Ouyang, Evrim Bengi Turkbey, Karinne Chevalier, Frederick L. Brancati, Diane M. Becker, Dhananjay M. Vaidya · 2013 · Diabetes Care
58. Peripheral Arterial Disease, Diabetes, and Mortality
    Leibson, Cynthia L., Ransom, Jeanine E., Olson, Wayne, Zimmerman, Bruce R., O’Fallon, W. Michael, Palumbo, Pasquale J. · 2004 · Diabetes Care
59. Intensive systolic blood pressure control and incident chronic kidney disease in people with and without diabetes mellitus: secondary analyses of two randomised controlled trials
    Beddhu, Srinivasan, Greene, Tom, Boucher, Robert, Cushman, William C, Wei, Guo, Stoddard, Gregory, Ix, Joachim H, Chonchol, Michel, Kramer, Holly, Cheung, Alfred K et al. · 2018 · The Lancet Diabetes & Endocrinology
60. Baseline prevalence of abdominal aortic aneurysm, peripheral arterial disease and hypertension in men aged 65–74 years from a population screening study (VIVA trial)
    Grøndal, N, Søgaard, R, Lindholt, J S · 2015 · British Journal of Surgery
61. Effects of physical activity and sedentary time on the risk of heart failure
    Young, Deborah Rohm, Reynolds, Kristi, Sidell, Margo, Brar, Somjot, Ghai, Nirupa R., Sternfeld, Barbara, Jacobsen, Steven J., Slezak, Jeffrey M., Caan, Bette, Quinn, Virginia P. · 2014 · Circulation: Heart Failure
62. Bariatric Surgery–Induced Cardiac and Lipidomic Changes in Obesity‐Related Heart Failure with Preserved Ejection Fraction
    Mikhalkova, Deana, Holman, Sujata R., Jiang, Hui, Saghir, Mohammed, Novak, Eric, Coggan, Andrew R., O'Connor, Robert, Bashir, Adil, Jamal, Ali, Ory, Daniel S. et al. · 2018 · Obesity
63. Effect of intensive blood pressure treatment on heart failure events in the systolic blood pressure reduction intervention trial
    Upadhya, Bharathi, Rocco, Michael, Lewis, Cora E., Oparil, Suzanne, Lovato, Laura C., Cushman, William C., Bates, Jeffrey T., Bello, Natalie A., Aurigemma, Gerard, Fine, Lawrence J. et al. · 2017 · Circulation: Heart Failure
64. Is "Isolated Home" Hypertension as Opposed to "Isolated Office" Hypertension a Sign of Greater Cardiovascular Risk?
    Bobrie, Guillaume, Genès, Nathalie, Vaur, Laurent, Clerson, Pierre, Vaisse, Bernard, Mallion, Jean-Michel, Chatellier, Gilles · 2001 · Archives of Internal Medicine
65. Pregnancy Outcomes in Familial Hypercholesterolemia: A Registry-Based Study
    Toleikyte, Ieva, Retterstøl, Kjetil, Leren, Trond Paul, Iversen, Per Ole · 2011 · Circulation
66. Effects of Cuff Size on the Accuracy of Blood Pressure Readings
    Junichi Ishigami, Jeanne B. Charleston, Edgar R. Miller · 2023 · JAMA Internal Medicine
67. Adherence to a Mediterranean Diet is Associated With Reduced Risk of Heart Failure in Men
    Tektonidis, Thanasis G., Åkesson, Agneta, Gigante, Bruna, Wolk, Alicja, Larsson, Susanna C. · 2016 · European Journal of Heart Failure
68. Cardiovascular and Renal Outcomes of Renin–Angiotensin System Blockade in Adult Patients with Diabetes Mellitus: A Systematic Review with Network Meta-Analyses
    Catalá-López, Ferrán, Macías Saint-Gerons, Diego, González-Bermejo, Diana, Rosano, Giuseppe M., Davis, Barry R., Ridao, Manuel, Zaragoza, Abel, Montero-Corominas, Dolores, Tobías, Aurelio, de la Fuente-Honrubia, César et al. · 2016 · PLOS Medicine
69. Impact and efficacy of mobile health intervention in the management of diabetes and hypertension: a systematic review and meta-analysis
    Mao, Yaqian, Lin, Wei, Wen, Junping, Chen, Gang · 2020 · BMJ Open Diabetes Research & Care
70. Cardiovascular and Kidney Outcomes Across the Glycemic Spectrum
    Honigberg, Michael C., Zekavat, Seyedeh M., Pirruccello, James P., Natarajan, Pradeep, Vaduganathan, Muthiah · 2021 · Journal of the American College of Cardiology
71. Effects of Intensive Blood Pressure Lowering on Cardiovascular and Renal Outcomes: Updated Systematic Review and Meta-Analysis
    X. Xie, E. Atkins, J. Lv · 2016 · Journal of Vascular Surgery
72. Diabetic Ketoacidosis With Canagliflozin, a Sodium–Glucose Cotransporter 2 Inhibitor, in Patients With Type 1 Diabetes
    Peters, Anne L., Henry, Robert R., Thakkar, Payal, Tong, Cindy, Alba, Maria · 2016 · Diabetes Care
73. Plasma N-terminal pro-brain natriuretic peptide as a major risk marker for cardiovascular disease in patients with type 2 diabetes and microalbuminuria
    G�de, P., Hildebrandt, P., Hess, G., Parving, H.-H., Pedersen, O. · 2005 · Diabetologia
74. Legacy benefits of blood glucose, blood pressure and lipid control in individuals with diabetes and cardiovascular disease: Time to overcome multifactorial therapeutic inertia?
    Khunti, Kamlesh, Kosiborod, Mikhail, Ray, Kausik K. · 2018 · Diabetes, Obesity and Metabolism
75. Harmonization of the American College of Cardiology/American Heart Association and European Society of Cardiology/European Society of Hypertension Blood Pressure/Hypertension Guidelines
    Paul Kieran Whelton, Robert M. Carey, Giuseppe Mancia, Reinhold Hugo Kreutz, Joshua D. Bundy, Bryan Williams · 2022 · European Heart Journal
76. High Prevalence of Peripheral Arterial Disease and Low Treatment Rates in Elderly Primary Care Patients with Diabetes
    Lange, S., Diehm, C., Darius, H., Haberl, R., Allenberg, J., Pittrow, D., Schuster, A., von Stritzky, B., Tepohl, G., Trampisch, H. · 2004 · Experimental and Clinical Endocrinology & Diabetes
77. Efficacy and safety of bempedoic acid among patients with and without diabetes: prespecified analysis of the CLEAR Outcomes randomised trial
    Ray, Kausik K, Nicholls, Stephen J, Li, Na, Louie, Michael J, Brennan, Danielle, Lincoff, A Michael, Nissen, Steven E · 2024 · The Lancet Diabetes & Endocrinology
78. Effects of Canagliflozin on Amino-Terminal Pro–B-Type Natriuretic Peptide
    Januzzi, James L., Xu, Jialin, Li, JingWei, Shaw, Wayne, Oh, Richard, Pfeifer, Michael, Butler, Javed, Sattar, Naveed, Mahaffey, Kenneth W., Neal, Bruce et al. · 2020 · Journal of the American College of Cardiology
79. Achieving Goal Blood Pressure in Patients With Type 2 Diabetes: Conventional Versus Fixed‐Dose Combination Approaches
    Bakris, George L., Weir, Matthew R., on behalf of the Study of Hypertension and the Efficacy of Lotrel in Diabetes (SHIELD) Investigators · 2003 · The Journal of Clinical Hypertension
80. The Effect of Canagliflozin, a Sodium Glucose Cotransporter 2 Inhibitor, on Glycemic End Points Assessed by Continuous Glucose Monitoring and Patient-Reported Outcomes Among People With Type 1 Diabetes
    Rodbard, Helena W., Peters, Anne L., Slee, April, Cao, Anjun, Traina, Shana B., Alba, Maria · 2017 · Diabetes Care
81. A Trial of 2 Strategies to Reduce Nocturnal Blood Pressure in Blacks With Chronic Kidney Disease
    Rahman, Mahboob, Greene, Tom, Phillips, Robert A., Agodoa, Lawrence Y., Bakris, George L., Charleston, Jeanne, Contreras, Gabriel, Gabbai, Francis, Hiremath, Leena, Jamerson, Kenneth et al. · 2013 · Hypertension
82. The relation of serum potassium concentration with cardiovascular events and mortality in community-living individuals
    Hughes-Austin, Jan M., Rifkin, Dena E., Beben, Tomasz, Katz, Ronit, Sarnak, Mark J., Deo, Rajat, Hoofnagle, Andrew N., Homma, Shunichi, Siscovick, David S., Sotoodehnia, Nona et al. · 2017 · Clinical Journal of the American Society of Nephrology
83. Syncope, Hypotension, and Falls in the Treatment of Hypertension: Results from the Randomized Clinical Systolic Blood Pressure Intervention Trial
    Sink, Kaycee M., Evans, Gregory W., Shorr, Ronald I., Bates, Jeffrey T., Berlowitz, Dan, Conroy, Molly B., Felton, Deborah M., Gure, Tanya, Johnson, Karen C., Kitzman, Dalane et al. · 2018 · Journal of the American Geriatrics Society
84. Prognostic Value of Ambulatory and Home Blood Pressures Compared With Office Blood Pressure in the General Population. Follow-up Results from the Pressioni Arteriose Monitorate e Loro Associazioni (PAMELA) Study
    Sega R., Rita Facchetti, M. Bombelli, G. Cesana · 2005 · ACC Current Journal Review
85. Impact of Cardiovascular Risk on the Relative Benefit and Harm of Intensive Treatment of Hypertension
    Phillips, Robert A., Xu, Jiaqiong, Peterson, Leif E., Arnold, Ryan M., Diamond, Joseph A., Schussheim, Adam E. · 2018 · Journal of the American College of Cardiology
86. Ticagrelor With or Without Aspirin in High-Risk Patients With Diabetes Mellitus Undergoing Percutaneous Coronary Intervention
    Angiolillo, Dominick J., Baber, Usman, Sartori, Samantha, Briguori, Carlo, Dangas, George, Cohen, David J., Mehta, Shamir R., Gibson, C. Michael, Chandiramani, Rishi, Huber, Kurt et al. · 2020 · Journal of the American College of Cardiology
87. Beta Blocker Use After Acute Myocardial Infarction in the Patient with Normal Systolic Function: When is it “Ok” to Discontinue?
    Anna Kezerashvili, Kevin Phillip Marzo, Joshua De Leon · 2012 · Current Cardiology Reviews
88. Use of Lipid-, Blood Pressure–, and Glucose-Lowering Pharmacotherapy in Patients With Type 2 Diabetes and Atherosclerotic Cardiovascular Disease
    Nelson, Adam J., O’Brien, Emily C., Kaltenbach, Lisa A., Green, Jennifer B., Lopes, Renato D., Morse, Caryn G., Al-Khalidi, Hussein R., Aroda, Vanita R., Cavender, Matthew A., Gaynor, Tanya et al. · 2022 · JAMA Network Open
89. Benefit and harm of intensive blood pressure treatment: Derivation and validation of risk models using data from the SPRINT and ACCORD trials
    Basu, Sanjay, Sussman, Jeremy B., Rigdon, Joseph, Steimle, Lauren, Denton, Brian T., Hayward, Rodney A. · 2017 · PLOS Medicine
90. Cardiovascular Outcomes Using Doxazosin vs. Chlorthalidone for the Treatment of Hypertension in Older Adults With and Without Glucose Disorders: A Report From the ALLHAT Study
    Barzilay, Joshua I., Davis, Barry R., Bettencourt, Judy, Margolis, Karen L., Goff, David C., Black, Henry, Habib, Gabriel, Ellsworth, Allan, Force, Rex W., Wiegmann, Thomas et al. · 2004 · The Journal of Clinical Hypertension
91. Statins and other lipid-lowering therapy and pregnancy outcomes in homozygous familial hypercholesterolaemia: A retrospective review of 39 pregnancies
    Botha, Theunis C., Pilcher, Gillian J., Wolmarans, Karen, Blom, Dirk J., Raal, Frederick J. · 2018 · Atherosclerosis
92. Association of Long-term Change and Variability in Glycemia With Risk of Incident Heart Failure Among Patients With Type 2 Diabetes: A Secondary Analysis of the ACCORD Trial
    Segar, Matthew W., Patel, Kershaw V., Vaduganathan, Muthiah, Caughey, Melissa C., Butler, Javed, Fonarow, Gregg C., Grodin, Justin L., McGuire, Darren K., Pandey, Ambarish · 2020 · Diabetes Care
93. Statins for primary prevention of cardiovascular disease
    Louise French, Jane W Smith · 2012 · Australian Prescriber
94. The prevalence of cardiovascular disease and antidiabetes treatment characteristics among a large type 2 diabetes population in the United States.
    Weng, Wayne, Tian, Ye, Kong, Sheldon X., Ganguly, Rahul, Hersloev, Malene, Brett, Jason, Hobbs, Todd · 2019 · Endocrinology, Diabetes & Metabolism
95. Metformin in Heart Failure
    Inzucchi, Silvio E., Masoudi, Frederick A., McGuire, Darren K. · 2007 · Diabetes Care
96. Diabetes Mellitus and Risk of New-Onset and Recurrent Heart Failure: A Systematic Review and Meta-Analysis
    Kodama*, Satoru, Fujihara, Kazuya, Horikawa, Chika, Sato, Takaaki, Iwanaga, Midori, Yamada, Takaho, Kato, Kiminori, Watanabe, Kenichi, Shimano, Hitoshi, Izumi, Tohru et al. · 2020 · ESC Heart Failure
97. Triglyceride-lowering therapies reduce cardiovascular disease event risk in subjects with hypertriglyceridemia
    Maki, Kevin C., Guyton, John R., Orringer, Carl E., Hamilton-Craig, Ian, Alexander, Dominik D., Davidson, Michael H. · 2016 · Journal of Clinical Lipidology
98. Effects of the Modified DASH Diet on Adults With Elevated Blood Pressure or Hypertension: A Systematic Review and Meta-Analysis
    Guo, Ru, Li, Nian, Yang, Rong, Liao, Xiao-Yang, Zhang, Yu, Zhu, Ben-Fu, Zhao, Qian, Chen, Lingmin, Zhang, Yong-Gang, Lei, Yi · 2021 · Frontiers in Nutrition
99. Randomized controlled trial comparing impact on platelet reactivity of twice‐daily with once‐daily aspirin in people with Type 2 diabetes
    Bethel, M. A., Harrison, P., Sourij, H., Sun, Y., Tucker, L., Kennedy, I., White, S., Hill, L., Oulhaj, A., Coleman, R. L. et al. · 2016 · Diabetic Medicine
100. Assessing the risk of ketoacidosis due to sodium-glucose cotransporter (SGLT)-2 inhibitors in patients with type 1 diabetes: A meta-analysis and meta-regression
     Musso, Giovanni, Sircana, Antonio, Saba, Francesca, Cassader, Maurizio, Gambino, Roberto · 2020 · PLOS Medicine
101. The 2018 AHA/ACC/AACVPR/AAPA/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA Guidelines on the Management of Blood Cholesterol in Diabetes
     Ronald B Goldberg, Neil J. Stone, Scott M. Grundy · 2020 · Diabetes Care
102. Real-world Evidence of Efficacy and Safety of SGLT2 Inhibitors as Adjunctive Therapy in Adults With Type 1 Diabetes: A European Two-Center Experience
     Ana Palanca, Falco van Nes, Felipe Pardo, Francisco Javier Ampudia‐Blasco, Chantal Mathieu · 2022 · Diabetes Care
103. Dyslipidemia management in women of reproductive potential: An Expert Clinical Consensus from the National Lipid Association
     Agarwala, Anandita, Dixon, Dave L., Gianos, Eugenia, Kirkpatrick, Carol F., Michos, Erin D., Satish, Priyanka, Birtcher, Kim K., Braun, Lynne T., Pillai, Priyamvada, Watson, Karol et al. · 2024 · Journal of Clinical Lipidology
104. Serial Measurement of Natriuretic Peptides and Cardiovascular Outcomes in Patients With Type 2 Diabetes in the EXAMINE Trial
     Jarolim, Petr, White, William B., Cannon, Christopher P., Gao, Qi, Morrow, David A. · 2018 · Diabetes Care
105. Diabetes Mellitus, Smoking, and the Risk for Asymptomatic Peripheral Arterial Disease: Whom Should We Screen?
     Eason, S. L., Petersen, N. J., Suarez-Almazor, M., Davis, B., Collins, T. C. · 2005 · The Journal of the American Board of Family Medicine
106. Individualizing Blood Pressure Targets for People With Diabetes and Hypertension: Comparing the ADA and the ACC/AHA Recommendations
     de Boer, Ian H., Bakris, George, Cannon, Christopher P. · 2018 · JAMA
107. Diabetes and Progression of Heart Failure
     Echouffo-Tcheugui, Justin B., Ndumele, Chiadi E., Zhang, Sui, Florido, Roberta, Matsushita, Kunihiro, Coresh, Josef, Skali, Hicham, Shah, Amil M., Selvin, Elizabeth · 2022 · Journal of the American College of Cardiology
108. In Vivo Platelet Activation and Aspirin Responsiveness in Type 1 Diabetes
     Zaccardi, Francesco, Rizzi, Alessandro, Petrucci, Giovanna, Ciaffardini, Flavia, Tanese, Luigi, Pagliaccia, Francesca, Cavalca, Viviana, Ciminello, Angela, Habib, Aida, Squellerio, Isabella et al. · 2016 · Diabetes
109. Pioglitazone and Risk of Cardiovascular Events in Patients With Type 2 Diabetes Mellitus: A Meta-analysis of Randomized Trials
     Lincoff, A. Michael, Wolski, Kathy, Nicholls, Stephen J., Nissen, Steven E. · 2007 · JAMA
110. Daily and intermittent rosuvastatin 5 mg therapy in statin intolerant patients: an observational study
     Meek, Claire, Wierzbicki, Anthony S., Jewkes, Christina, Twomey, Patrick J., Crook, Martin A., Jones, Alan, Viljoen, Adie · 2012 · Current Medical Research and Opinion
111. Association between statin use and cognitive function: A systematic review of randomized clinical trials and observational studies
     Adhikari, Anish, Tripathy, Swetapadma, Chuzi, Sarah, Peterson, Jonna, Stone, Neil J. · 2021 · Journal of Clinical Lipidology
112. Determinants of Reduced Antiplatelet Effect of Aspirin in Patients with Stable Coronary Artery Disease
     Sanne Bøjet Larsen, Erik Lerkevang Grove, Søs Neergaard‐Petersen, Morten Würtz, Anne‐Mette Hvas, Steen Dalby Kristensen · 2015 · PLoS ONE
113. Evening‐ versus morning‐dosing‐regimen drug therapy for hypertension
     2011 · Prescriber
114. The Influence of Baseline Diastolic Blood Pressure on the Effects of Intensive Blood Pressure Lowering on Cardiovascular Outcomes and All-Cause Mortality in Type 2 Diabetes
     Ilkun, Olesya L., Greene, Tom, Cheung, Alfred K., Whelton, Paul K., Wei, Guo, Boucher, Robert E., Ambrosius, Walter, Chertow, Glenn M., Beddhu, Srinivasan · 2020 · Diabetes Care
115. Pravastatin in preeclampsia: A meta-analysis and systematic review
     Mészáros, Balázs, Veres, Dániel Sándor, Nagyistók, Luca, Somogyi, Anikó, Rosta, Klára, Herold, Zoltán, Kukor, Zoltán, Valent, Sándor · 2023 · Frontiers in Medicine
116. Safety and efficacy of bempedoic acid: a systematic review and meta-analysis of randomised controlled trials
     De Filippo, Ovidio, D’Ascenzo, Fabrizio, Iannaccone, Mario, Bertaina, Maurizio, Leone, Attilio, Borzillo, Irene, Ravetti, Emanuele, Solano, Andrea, Pagliassotto, Ilaria, Nebiolo, Marco et al. · 2023 · Cardiovascular Diabetology
117. Efficacy and Safety of Atorvastatin in the Prevention of Cardiovascular End Points in Subjects With Type 2 Diabetes: The Atorvastatin Study for Prevention of Coronary Heart Disease Endpoints in Non-Insulin-Dependent Diabetes Mellitus (ASPEN)
     Robert H. Knopp, on behalf of the ASPEN Study Group · 2006 · Diabetes Care
118. Low-Dose Aspirin in the Primary Prevention of Cardiovascular Disease
     Samia Mora, Jeffrey M. Ames, JoAnn E. Manson · 2016 · JAMA
119. Association Between Lipid Testing and Statin Adherence in the Veterans Affairs Health System
     Jia, Xiaoming, Al Rifai, Mahmoud, Ramsey, David J., Ahmed, Sarah T., Akeroyd, Julia M., Nambi, Vijay, Ballantyne, Christie M., Petersen, Laura A., Stone, Neil J., Virani, Salim S. · 2019 · The American Journal of Medicine
120. Effects of aspirin for primary prevention in persons with diabetes mellitus: the ASCEND Study Collaborative Group
     Louise J. Bowman, Marion M. Mafham, Karl Wallendszus · 2018 · Journal of Vascular Surgery
121. Association of Low-Density Lipoprotein Testing After an Atherosclerotic Cardiovascular Event with Subsequent Statin Adherence and Intensification
     Rana, Jamal S., Virani, Salim S., Moffet, Howard H., Liu, Jennifer Y., Coghlan, Landis A., Vasadia, Jitesh, Ballantyne, Christie M., Karter, Andrew J. · 2022 · The American Journal of Medicine
122. Advancing Digital Health Interventions as a Clinically Applied Science for Blood Pressure Reduction: A Systematic Review and Meta-analysis
     Stogios, Nicolette, Kaur, Bhagwanpreet, Huszti, Ella, Vasanthan, Jessica, Nolan, Robert P. · 2020 · Canadian Journal of Cardiology
123. Association Between Triglycerides and Residual Cardiovascular Risk in Patients With Type 2 Diabetes Mellitus and Established Cardiovascular Disease (From the Bypass Angioplasty Revascularization Investigation 2 Diabetes [BARI 2D] Trial)
     Adam J. Nelson, Ann Marie Návar, Hillary S. Mulder, DANIEL M. WOJDYLA, Sephy Philip, Craig B. Granowitz, Eric David Peterson, Neha Jadeja Pagidipati · 2020 · The American Journal of Cardiology
124. Cardiovascular prognostic value of echocardiography and N terminal pro B-type natriuretic peptide in type 1 diabetes: the Thousand & 1 Study
     Rørth, Rasmus, Jørgensen, Peter Godsk, Andersen, Henrik Ullits, Christoffersen, Christina, Gøtze, Jens Peter, Køber, Lars, Rossing, Peter, Jensen, Magnus Thorsten · 2020 · European Journal of Endocrinology
125. Ambulatory and home blood pressure monitoring for cardiovascular disease risk evaluation: a systematic review and meta-analysis of prospective cohort studies
     Demosthenes B. Panagiotakos, Christina Antza, Vasilios Kotsis · 2023 · Journal of Hypertension
126. Value of Coronary Computed Tomography Angiography in Tailoring Aspirin Therapy for Primary Prevention of Atherosclerotic Events in Patients at High Risk With Diabetes Mellitus
     Aukelien C. Dimitriu‐Leen, Arthur J.H.A. Scholte, Alexander R. van Rosendael, Inge J. van den Hoogen, A. V. Kharagjitsingh, Ron Wolterbeek, Juhani M. Knuuti, Lucia J.M. Kroft, Victoria Delgado, J. Wouter Jukema et al. · 2015 · The American Journal of Cardiology
127. Microvascular disease increases the risk of lower limb amputation – A Western Danish cohort study
     Olesen, Kevin Kris Warnakula, Anand, Sonia, Thim, Troels, Gyldenkerne, Christine, Maeng, Michael · 2022 · European Journal of Clinical Investigation
128. Pharmacogenetic study of statin therapy and cholesterol reduction
     Daniel I. Chasman, David Posada, L. Subrahmanyam · 2004 · ACC Current Journal Review
129. Introduction: Standards of Care in Diabetes—2024 Abridged for Primary Care Professionals
     Nuha A. ElSayed, Arshiya A. Baig, Sarah Bradley et al. · 2024 · Clinical Diabetes
130. Rising to the challenge of cardio-renal-metabolic disease in the 21st century: Translating evidence into best clinical practice to prevent and manage atherosclerosis
     Andrew J. Krentz, Stephan Jacob, Christian Heiß, Naveed A. Sattar, Soo Kyung Lim, Kamlesh K. Khunti, Robert H. Eckel · 2024 · Atherosclerosis
131. Adherence to lipid monitoring and its impact on treatment intensification of LDL-C lowering therapies at an urban academic medical center
     Tran, Christine, Vo, Victoria, Taylor, Perry, Koehn, Deborah A., Virani, Salim S., Dixon, Dave L. · 2022 · Journal of Clinical Lipidology
132. Effect of more versus less intensive blood pressure control on cardiovascular, renal and mortality outcomes in people with type 2 diabetes: A systematic review and meta-analysis
     Ekaterini Ioannidou, Sharmin Shabnam, Sophia C. Abner, Navjot Kaur, Francesco Zaccardi, Kausik Kumar Ray, Samuel Seidu, Melanie Jane Davies, Kamlesh K. Khunti, Clare L. Gillies · 2023 · Diabetes & Metabolic Syndrome Clinical Research & Reviews
133. Effects of Sotagliflozin Added to Insulin in Type 1 Diabetes
     Nithya J Gogtay, Debdipta Bose, Urmila M Thatte · 2018 · New England Journal of Medicine
134. Early aspirin discontinuation after coronary stenting: a systematic review and meta-analysis
     Wiebe, Jens, Ndrepepa, Gjin, Kufner, Sebastian, Lahmann, Anna L., Xhepa, Erion, Kuna, Constantin, Voll, Felix, Gosetti, Rosanna, Laugwitz, Karl‐Ludwig, Joner, Michael et al. · 2021 · Journal of the American Heart Association
135. Evening versus morning dosing regimen drug therapy for hypertension
     Chuncheng Wu, Ping Zhao, Ping Xu, Chaomin Wan, Surjit Singh, Shoban Babu Varthya, Shuanghong Luo · 2024 · Cochrane Database of Systematic Reviews
136. Effect of type 2 diabetes and its duration on the risk of peripheral arterial disease among men
     Wael K. Al‐Delaimy, Anwar T. Merchant, Eric B. Rimm · 2004 · ACC Current Journal Review
137. Efficacy and Safety of Dapagliflozin in Patients with Inadequately Controlled Type 1 Diabetes—DEPICT-2 Study
     Chantal Mathieu, Paresh Dandona, Pieter Gillard, Peter Alexander Senior, Christoph Hasslacher, Eiichi Araki, Marcus Lind, Stephen Charles Bain, Serge A Jabbour, Niki Arya et al. · 2018 · Diabetes
138. Peripheral Artery Disease Screening in the Community and 1-Year Mortality, Cardiovascular Events, and Adverse Limb Events
     Smolderen, Kim G., Ameli, Omid, Chaisson, Christine E., Heath, Kevin, Mena-Hurtado, Carlos · 2022 · AJPM Focus
139. The Nevada peripheral artery disease screening effort in a Medicare Advantage population and subsequent mortality and major adverse cardiovascular event risk
     Smolderen, Kim G., Heath, Kevin, Scherr, Terry, Bauzon, Samuel R., Howell, Amy Nguyen, Mena-Hurtado, Carlos · 2022 · Journal of Vascular Surgery
140. Effect of a Multifactorial Intervention on Mortality in Type II Diabetes
     P. Gaede, H. Lund-Andersen, Hans‐Henrik Parving · 2008 · Journal of Vascular Surgery
141. Chronic Hypertension and Pregnancy (CHAP) Trial Consortium. Treatment for Mild Chronic Hypertension During Pregnancy
     A.T. Tita, Jeff M. Szychowski, K. A. Boggess, Lorraine Dugoff, Baha M. Sibai, et al · 2022 · Obstetric Anesthesia Digest
142. Long-term Risk of Cardiovascular Events With Rosiglitazone: A Meta-analysis
     Singh, Sonal, Loke, Yoon K., Furberg, Curt D. · 2007 · JAMA
143. Statin use and risk of dementia and Alzheimer’s disease: A meta-analysis of observational studies
     Elena Olmastroni, Federica Galimberti, Margherita Gazzotti, A. Zambon, Alberico Luigi Catapano, Matteo Casula · 2022 · Atherosclerosis
144. Bempedoic Acid for Primary Prevention of Cardiovascular Events—Reply
     Steven E. Nissen, Stephen James Nicholls, Abraham Michael Lincoff · 2023 · JAMA
145. Real-world Evidence of Efficacy and Safety of Sodium–Glucose Cotransporter 2 Inhibitors as Adjunctive Therapy in Adults With Type 1 Diabetes: A European Two-Center Experience
     Ana Palanca, Falco van Nes, Felipe Pardo · 2022
146. The influence of baseline diastolic blood pressure on the effects of intensive blood pressure lowering on cardiovascular outcomes and all-cause mortality in type 2 diabetes mellitus
     Olesya L. Ilkun, Tom Greene, Alfred K. Cheung · 2020
147. Safety and Efficacy of Bempedoic Acid: A Systematic Review and Metanalysis of Randomised Controlled Trials
     Ovidio DE FILIPPO, Fabrizio D’Ascenzio, Mario Iannaccone, Maurizio Bertaina, Attilio Leone, Irene Borzillo, Emanuele Ravetti, Andrea Solano, Ilaria Pagliassotto, Marco Nebiolo et al. · 2023 · SSRN Electronic Journal
148. CARDIOVASCULAR AND RENAL OUTCOMES ACROSS THE GLYCEMIC SPECTRUM: INSIGHTS FROM THE UK BIOBANK
     Michael Honigberg, Seyedeh M. Zekavat, James Pirruccello · 2021 · Journal of the American College of Cardiology
149. AMBULATORY AND HOME BLOOD PRESSURE MONITORING FOR CARDIOVASCULAR DISEASE RISK EVALUATION: A SYSTEMATIC REVIEW AND META-ANALYSIS OF PROSPECTIVE COHORT STUDIES
     Demosthenes Panagiotakos, Christina Antza, Vasilios Kotsis · 2024 · Journal of Hypertension
150. 187. The hypertensive disorders of pregnancy: ISSHP classification, diagnosis & management recommendations for international practice
     Mark Brown, Laura Magee, Louise Kenny · 2018 · Pregnancy Hypertension
151. Corrigendum: Effects of the Modified DASH Diet on Adults With Elevated Blood Pressure or Hypertension: A Systematic Review and Meta-Analysis
     Ru Guo, Nian Li, Rong Yang · 2021 · Frontiers in Nutrition
152. 882-1 Anglo-scandinavian cardiac outcomes trial — lipid-lowering arm (ASCOT-LLA): Results in the subgroup of patients with diabetes
     Peter S Sever, Bjorn Dahlof, Neil Poulter, Hans Wedel · 2004 · Journal of the American College of Cardiology
153. Triglyceride-Lowering Therapies Reduce Cardiovascular Disease Event Risk in Subjects with Hypertriglyceridemia
     Kevin C. Maki, Michael H. Davidson, John R. Guyton, Carl E. Orringer, Ian Hamilton-Craig, Dominik D. Alexander · 2015 · Journal of Clinical Lipidology
154. The Prevention of Progression of Arterial Disease and Diabetes (POPADAD) Trial: Factorial Randomised Placebo Controlled Trial of Aspirin and Antioxidants in Patients with Diabetes and Asymptomatic Peripheral Arterial Disease
     J. Belch, A. MacCuish, I. Campbell · 2009 · Journal of Vascular Surgery
155. Statin and Other Lipid-Lowering Therapy and Pregnancy Outcomes in Homozygous Familial Hypercholesterolaemia
     Theunis C. Botha, Frederick J. Raal, Dirk J. Blom, Gillian J. Pilcher, Karen Wolmarans · 2018 · Atherosclerosis Supplements
156. Heart Failure: An Underappreciated Complication of Diabetes. A Consensus Report of the American Diabetes Association
     Rodica Pop-Busui, James L Januzzi, Dennis Bruemmer · 2022
157. REDUCTION IN ISCHEMIC EVENTS WITH TICAGRELOR IN DIABETIC PATIENTS FROM THE PEGASUS-TIMI 54 TRIAL
     Deepak L. Bhatt, Marc Bonaca, Sameer Bansilal, Marc Cohen, Robert F. Storey, Kyungah Im, Sabina Murphy, Peter Held, Eugene Braunwald, Marc Sabatine et al. · 2016 · Journal of the American College of Cardiology
158. Rivaroxaban in Peripheral Artery Disease After Revascularization
     M.P. Bonaca, R.M. Bauersachs, S.S. Anand, E.S. Debus, M.R. Nehler, M.R. Patel · 2020 · Journal of Vascular Surgery
159. Corrigendum to “Rising to the challenge of cardio-renal-metabolic disease in the 21st century: Translating evidence into best clinical practice to prevent and manage atherosclerosis” [Atherosclerosis, Vol 396, (September 2024), 118528]
     Andrew Krentz, Stephan Jacob, Christian Heiss · 2024 · Atherosclerosis
160. Shared Decision Making Regarding Aspirin in Primary Prevention of Cardiovascular Disease—Reply
     Samia Mora, JoAnn E. Manson · 2016 · JAMA